PDRN injection is a skin rejuvenation treatment made of biological molecules called Polydeoxyribonucleotide (PDRN). A PDRN molecule is a polymer consisting of 13 or more deoxyribonucleotide monomers. A nucleotide is a monomer building blocks found in DNA or RNA and Deoxyribonucleotide is a nucleotide built from deoxyribose sugars.The DNA extract is obtained from the testis of salmon, then fragmented into PDRNs.
PDRN produces significant tissue improvement and consistency throughout the treatment period. PDRN was first deployed as a tissue repairing compound in Italy after approved PDRN in 2008 due to its special ability to accelerate recovery after skin grafts. PDRN can be use with mesotherapy processes because it can stimulate the metabolic activity of cells in the skin to regenerate collagen, glycosaminoglycans and glycoproteinswound. PNs stimulate wound recovery through antigenesis enhancement and boost rates of growth in fibroblasts. Which means PDRN can awaken tired aged cells to act younger and get to work again. PDRN Mesotherapy makes a significant improvement in skin elasticity, texture and hydration. With PDRN, also called the baby skin boosters treatment, which has been proven to be effective and safe through dermatology clinics for cell growth and tissue regeneration.
What are the benefits of PDRN Mesotherapy?
- Improved skin elasticity
- Improved Hydration
- Reduced fine lines and wrinkles
- Skin repair – with improved skin barrier function
- Skin normalization – thickening of skin, regulation of oil production
- Improved skin tone
- Improved skin texture
HP Nucleo Vital combines 2000 ppm of PDRN and 5000 ppm of Hyaluric Acid, has taken over the role of PDRN products. Combine one Glamour Hyaluronic Acid skinboosters syringe with one bottle of HP Nucleo Vital to reach the best result you want.
Topical application, can be combined with the most advanced technologies : skinboosters injection machine, micro-needling, electrodraining, RF needle, Fractionated Pulsed light and electrophoroporation.
2,144 total views, 11 views today